Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats
    Published on 2024-09-06
    2 years ago
  • Astrocytic RARγ mediates hippocampal astrocytosis and neurogenesis deficits in chronic retinoic acid-induced depression
    Published on 2024-09-06
    2 years ago
  • Reporting checklists in neuroimaging: promoting transparency, replicability, and reproducibility
    Published on 2024-09-06
    2 years ago
  • Revisiting the role of computational neuroimaging in the era of integrative neuroscience
    Published on 2024-09-06
    2 years ago
  • Prenatal exposure to the mineralocorticoid receptor antagonist spironolactone disrupts hippocampal area CA2 connectivity and alters behavior in mice
    Published on 2024-09-05
    2 years ago
  • GLP-1 receptor agonist exenatide uncouples food intake from hedonic and anticipatory regulation in non-human primates: insights from an operant meal schedule paradigm
    Published on 2024-09-04
    2 years ago
  • Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome
    Published on 2024-09-02
    2 years ago
« Previous 1 … 66 67 68 69 70 … 143 Next »
Journal of Psychopharmacology
  • Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption
    Published on 2022-12-14
    3 years ago
  • Effects of modafinil and caffeine on night-time vigilance of air force crewmembers: A randomized controlled trial
    Published on 2022-12-14
    3 years ago
  • Effects of clozapine treatment on the improvement of substance use disorders other than nicotine in individuals with schizophrenia spectrum disorders: A systematic review and meta-analysis
    Published on 2022-12-12
    3 years ago
  • Common practical questions – and answers – at the British Association for Psychopharmacology child and adolescent psychopharmacology course
    Published on 2022-12-07
    3 years ago
  • Characteristics of poisonings involving ketamine in the United States, 2019–2021
    Published on 2022-12-07
    3 years ago
  • Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression
    Published on 2022-11-26
    4 years ago
  • Regular cannabis use modulates the impact of HIV on the neural dynamics serving cognitive control
    Published on 2022-11-23
    4 years ago
« Previous 1 … 66 67 68 69 70 … 145 Next »
European Neuropsychopharmacology
  • Clinician- versus caregiver-rated scales as outcome measures of repetitive-restricted behaviors in clinical trials of autism: A systematic review and meta-analysis
    Published on 2023-03-03
    3 years ago
  • Fortification of drinking water with lithium to reduce suicide in the population
    Published on 2023-03-02
    3 years ago
  • Effective patient-physician communication in the era of neuropsychopharmacology
    Published on 2023-03-02
    3 years ago
  • Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?
    Published on 2023-03-02
    3 years ago
  • Hard variables for shared decision-making in antipsychotic maintenance treatment
    Published on 2023-03-01
    3 years ago
  • Association between the loudness dependence of auditory evoked potential, serotonergic neurotransmission and treatment outcome in patients with depression
    Published on 2023-03-01
    3 years ago
  • FDG/Raclopride-PET neuroimaging in work-related stress – A systematic review
    Published on 2023-02-28
    3 years ago
« Previous 1 … 66 67 68 69 70 … 166 Next »

   Pharma Pub